{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:58:26Z","timestamp":1794362306487,"version":"4.9.0"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Schnitzler syndrome is a rare disease of adult-onset with main features including chronic urticarial rash, recurrent fever, arthralgia or arthritis, monoclonal gammopathy of undetermined significance (MGUS), and marked systemic inflammation. Schnitzler syndrome is often underdiagnosed. Patients with Schnitzler syndrome may present to dermatologists and allergists for urticaria, hematologists for MGUS, or rheumatologists for arthritis. It is important to recognize Schnitzler syndrome for its remarkable response to interleukin (IL)-1 blockade. Besides, many cases of Schnitzler-like syndromes do not meet the diagnostic criteria of classical Schnitzler syndrome but display excellent response to IL-1 inhibitors. The overly produced IL-1 is the result of a somatic mosaic gain of function mutation of <jats:italic toggle=\"yes\">NLRP3<\/jats:italic> (nucleotide-binding oligomerization domain [NOD]-like receptor [NLR] family pyrin domain containing 3) gene in some patients with Schnitzler-like syndromes. Inflammasome activation is evident in patients with classical Schnitzler syndrome although no <jats:italic toggle=\"yes\">NLRP3<\/jats:italic> gene mutation is identified. Collectively, Schnitzler syndrome and Schnitzler-like syndromes represent a spectrum of IL-1 mediated adult-onset autoinflammatory diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002015","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T23:21:08Z","timestamp":1643412068000},"page":"1190-1202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Schnitzler syndrome and Schnitzler-like syndromes"],"prefix":"10.1097","volume":"135","author":[{"given":"Cong-Qiu","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"R2-20250603","first-page":"363","article-title":"Urticaire chronique, l\u00e9sions osseuses, macroglobulin\u00e9mie IgM: Maladie de Waldenstrom","volume":"81","author":"Schnitzler","year":"1974","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200101000-00004","article-title":"The Schnitzler syndrome. Four new cases and review of the literature","volume":"80","author":"Lipsker","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler's syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2045-7022-4-41","article-title":"Schnitzler's syndrome: lessons from 281 cases","volume":"4","author":"de Koning","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1027-8117(10)60017-1","article-title":"Long-term control of refractory Schnitzler syndrome with anakinra: a case report","volume":"28","author":"Chiu","year":"2010","journal-title":"Dermatologica Sinica"},{"key":"R7-20250603","first-page":"742","article-title":"A case of Schnitzler's syndrome (in Chinese)","volume":"50","author":"Su","year":"2017","journal-title":"Chin J Dermatol"},{"key":"R8-20250603","first-page":"523","article-title":"Schnitzler syndrome: a case report (in Chinese)","volume":"39","author":"Wang","year":"2018","journal-title":"Chin J Hematol"},{"key":"R9-20250603","first-page":"792","article-title":"Schnitzler syndrome (in Chinese)","volume":"46","author":"Wang","year":"2013","journal-title":"Chin J Dermatol"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s10067-020-05204-2","article-title":"A Chinese case series of Schnitzler syndrome and complete remission in one tocilizumab-treated patient","volume":"39","author":"Yan","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bjd.19808","article-title":"Inducible skin-associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema","volume":"184","author":"Kamido","year":"2021","journal-title":"Br J Dermatol"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1111\/ijd.12300","article-title":"Successful treatment of Schnitzler syndrome with cyclosporine","volume":"53","author":"Nakajima","year":"2014","journal-title":"Int J Dermatol"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3324\/haematol.2013.084830","article-title":"Schnitzler syndrome: an under-diagnosed clinical entity","volume":"98","author":"Jain","year":"2013","journal-title":"Haematologica"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4065\/84.8.685","article-title":"Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients","volume":"84","author":"Bida","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00277-011-1293-1","article-title":"Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany","volume":"91","author":"Eisele","year":"2012","journal-title":"Ann Hematol"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment","volume":"37","author":"de Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/all.13035","article-title":"Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients","volume":"72","author":"Gusdorf","year":"2017","journal-title":"Allergy"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2214\/ajr.175.5.1751325","article-title":"Schnitzler's syndrome: an unusual cause of bone pain with suggestive imaging features","volume":"175","author":"De Waele","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00256-014-1857-y","article-title":"Imaging findings in 22 cases of Schnitzler syndrome: characteristic para-articular osteosclerosis, and the \u201chot knees\u201d sign differential diagnosis","volume":"43","author":"Niederhauser","year":"2014","journal-title":"Skeletal Radiol"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08916934.2019.1680649","article-title":"Diagnostic value of 18-F fluorodeoxyglucose PET\/CT and bone scan in Schnitzler syndrome","volume":"52","author":"Alix","year":"2019","journal-title":"Autoimmunity"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13075-020-02318-5","article-title":"Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patients","volume":"22","author":"Darrieutort-Laffite","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.beha.2005.01.024","article-title":"Neurological aspects of multiple myeloma and related disorders","volume":"18","author":"Dispenzieri","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2003-41131","article-title":"Antibody-associated polyneuropathy syndromes: principles and treatment","volume":"23","author":"Kornberg","year":"2003","journal-title":"Semin Neurol"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2005.045245","article-title":"Beneficial response to anakinra and thalidomide in Schnitzler's syndrome","volume":"65","author":"de Koning","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10067-010-1375-9","article-title":"Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review","volume":"29","author":"Besada","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MD.0b013e3181943f5e","article-title":"Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature","volume":"88","author":"Kieffer","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaip.2018.05.006","article-title":"Mimickers of urticaria: urticarial vasculitis and autoinflammatory diseases","volume":"6","author":"Davis","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.15705","article-title":"Use of skin biomarker profiles to distinguish Schnitzler syndrome from chronic spontaneous urticaria: results of a pilot study","volume":"178","author":"Bonnekoh","year":"2018","journal-title":"Br J Dermatol"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/bjd.13857","article-title":"Mast-cell interleukin-1beta, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome","volume":"173","author":"de Koning","year":"2015","journal-title":"Br J Dermatol"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"463\u2013468.e3","DOI":"10.1016\/j.jaip.2020.07.058","article-title":"Canakinumab lacks efficacy in treating adult patients with moderate to severe chronic spontaneous urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study","volume":"9","author":"Maul","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.41030","article-title":"Exploratory study of MYD88 L265P, rare NLRP3 variants, and clonal hematopoiesis prevalence in patients with Schnitzler syndrome","volume":"71","author":"Pathak","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2017-10-810366","article-title":"Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome","volume":"131","author":"Rowczenio","year":"2018","journal-title":"Blood"},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar4171","article-title":"Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature","volume":"15","author":"Rowczenio","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2009.10.066","article-title":"Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome","volume":"125","author":"Loock","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jdcr.2019.02.002","article-title":"Schnitzler syndrome associated with MYD88 L265P mutation","volume":"5","author":"Goodman","year":"2019","journal-title":"JAAD Case Rep"},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaci.2014.07.050","article-title":"Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome","volume":"135","author":"de Koning","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/art.39770","article-title":"Brief report: late-onset cryopyrin-associated periodic syndrome due to myeloid-restricted somatic NLRP3 mosaicism","volume":"68","author":"Mensa-Vilaro","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R40-20250603","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3389\/fimmu.2017.01410","article-title":"Late-onset cryopyrin-associated periodic syndromes caused by somatic NLRP3 mosaicism-UK single center experience","volume":"8","author":"Rowczenio","year":"2017","journal-title":"Front Immunol"},{"key":"R41-20250603","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/art.39190","article-title":"Brief report: cryopyrin-associated periodic syndrome caused by a myeloid-restricted somatic NLRP3 mutation","volume":"67","author":"Zhou","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R42-20250603","doi-asserted-by":"crossref","first-page":"588322","DOI":"10.3389\/fimmu.2020.588322","article-title":"Cytokine signature in Schnitzler syndrome: proinflammatory cytokine production associated to Th suppression","volume":"11","author":"Masson Regnault","year":"2020","journal-title":"Front Immunol"},{"key":"R43-20250603","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1684\/ecn.2009.0164","article-title":"Free circulating interleukin-18 is increased in Schnitzler syndrome: a new auto-inflammatory disease?","volume":"20","author":"Migliorini","year":"2009","journal-title":"Eur Cytokine Netw"},{"key":"R44-20250603","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2017.10.006","article-title":"Schnitzler syndrome with IgG gammopathy and elevated IL-1beta and IL-17 in skin biopsy","volume":"120","author":"Villarreal","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R45-20250603","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"R46-20250603","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2019.00546","article-title":"Skin and systemic inflammation in Schnitzler's syndrome are associated with neutrophil extracellular trap formation","volume":"10","author":"Bonnekoh","year":"2019","journal-title":"Front Immunol"},{"key":"R47-20250603","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/bjd.17334","article-title":"Association of CCL2 with systemic inflammation in Schnitzler syndrome","volume":"180","author":"Krause","year":"2019","journal-title":"Br J Dermatol"},{"key":"R48-20250603","doi-asserted-by":"crossref","first-page":"569006","DOI":"10.3389\/fimmu.2020.569006","article-title":"Evidence of B cell clonality and investigation into properties of the IgM in patients with Schnitzler syndrome","volume":"11","author":"Pathak","year":"2020","journal-title":"Front Immunol"},{"key":"R49-20250603","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/03009742.2010.507219","article-title":"Characterization of the B-cell compartment in a patient with Schnitzler syndrome","volume":"40","author":"Sediva","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"R50-20250603","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.autrev.2014.08.031","article-title":"Long-term effectiveness and safety ofinterleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study","volume":"13","author":"Neel","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R51-20250603","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/1346-8138.16124","article-title":"Refractory serum immunoglobulin M elevation during anti-interleukin (IL)-1- or IL-6-targeted treatment in four patients with Schnitzler syndrome","volume":"48","author":"Takimoto-Ito","year":"2021","journal-title":"J Dermatol"},{"key":"R52-20250603","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/03009742.2018.1550210","article-title":"Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome","volume":"48","author":"Migliorini","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"R53-20250603","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1016\/j.jaad.2011.10.002","article-title":"Elevated interleukin-18 secretion from monoclonal IgM+ B cells in a patient with Schnitzler syndrome","volume":"67","author":"Bhattacharyya","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R54-20250603","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.4049\/jimmunol.165.12.6880","article-title":"Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells","volume":"165","author":"Airoldi","year":"2000","journal-title":"J Immunol"},{"key":"R55-20250603","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.4049\/jimmunol.177.7.4627","article-title":"Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa","volume":"177","author":"Kinoshita","year":"2006","journal-title":"J Immunol"},{"key":"R56-20250603","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1078-0432.CCR-1026-3","article-title":"Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes","volume":"10","author":"Airoldi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R57-20250603","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaad.2012.04.027","article-title":"Clinical and histopathologic review of Schnitzler syndrome: the Mayo Clinic experience (19722011)","volume":"67","author":"Sokumbi","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R58-20250603","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ced.12828","article-title":"Clinical characterization and long-term follow-up of Schnitzler syndrome","volume":"41","author":"Gameiro","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"R59-20250603","doi-asserted-by":"crossref","first-page":"15","DOI":"10.36290\/vnl.2021.046","article-title":"Transformation of IgM-MGUS into Waldenstrom s macroglobuli-nemia in two of six patients treated for Schnitzler s syndrome","volume":"67","author":"Adam","year":"2021","journal-title":"Vnitr Lek"},{"key":"R60-20250603","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/annrheumdis-2012-202192","article-title":"Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome","volume":"72","author":"de Koning","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R61-20250603","doi-asserted-by":"crossref","first-page":"1681\u20131686.e5","DOI":"10.1016\/j.jaci.2019.12.909","article-title":"Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome","volume":"145","author":"Krause","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R62-20250603","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","article-title":"Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study","volume":"139","author":"Krause","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R63-20250603","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autrev.2012.07.016","article-title":"Amyloidosis in autoinflammatory syndromes","volume":"12","author":"Obici","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R64-20250603","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.21101","article-title":"Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al","volume":"52","author":"Martinez-Taboada","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R65-20250603","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-5-38","article-title":"The Schnitzler syndrome","volume":"5","author":"Lipsker","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R66-20250603","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2011.10.031","article-title":"Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome","volume":"129","author":"Krause","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R67-20250603","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.semarthrit.2020.05.002","article-title":"Efficacy and safety of canakinumab treatment in schnitzler syndrome: a systematic literature review","volume":"50","author":"Betrains","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R68-20250603","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm811","article-title":"Cytokine traps: multi-component, high-affinity blockers of cytokine action","volume":"9","author":"Economides","year":"2003","journal-title":"Nat Med"},{"key":"R69-20250603","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2012.02843.x","article-title":"Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"R70-20250603","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1185\/03007990802297495","article-title":"Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity","volume":"24","author":"Hoffman","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"R71-20250603","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10875-019-00644-1","article-title":"Variable responses to tocilizumab in four patients with Schnitzler syndrome","volume":"39","author":"Claus","year":"2019","journal-title":"J Clin Immunol"},{"key":"R72-20250603","doi-asserted-by":"crossref","first-page":"2486\u20132489.e4","DOI":"10.1016\/j.jaip.2021.01.024","article-title":"Tocilizumab treatment in patients with Schnitzler syndrome: an open-label study","volume":"9","author":"Bonnekoh","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R73-20250603","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2133.2007.07799.x","article-title":"Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab","volume":"156","author":"Ramadan","year":"2007","journal-title":"Br J Dermatol"},{"key":"R74-20250603","first-page":"660","article-title":"Impairment of renal function in Schnitzler's syndrome","volume":"19","author":"Westhoff","year":"2006","journal-title":"J Nephrol"},{"key":"R75-20250603","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaad.2008.12.040","article-title":"Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy","volume":"61","author":"Murota","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R76-20250603","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/039463201002300226","article-title":"Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial","volume":"23","author":"Cascavilla","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R77-20250603","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2007.03.036","article-title":"Schnitzler syndrome: treatment failure to rituximab but response to anakinra","volume":"57","author":"Eiling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R78-20250603","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.autrev.2011.01.003","article-title":"Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature","volume":"10","author":"Tinazzi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R79-20250603","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000368349","article-title":"Complete remission of Schnitzler syndrome and Waldenstrom macroglobulinemia under rituximab-cyclophospha-mide-dexamethasone","volume":"230","author":"Aouba","year":"2015","journal-title":"Dermatology"},{"key":"R80-20250603","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jbspin.2010.02.016","article-title":"Schnitzler's syndrome improvement after anti-TNF-alpha therapy","volume":"77","author":"Aikawa","year":"2010","journal-title":"Joint Bone Spine"},{"key":"R81-20250603","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/rheumatology\/kem048","article-title":"Schnitzler's syndrome - exacerbation after anti-TNF treatment","volume":"46","author":"Thonhofer","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R82-20250603","first-page":"1161","article-title":"Schnitzler's syndrome with biclonal gammopathy successfully treated with hydroxychloroquine and low dose steroids","volume":"26","author":"Lagana","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"R83-20250603","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4172\/2155-9899.1000265","article-title":"Schnitzler's syndrome in the absence of a monoclonal gammopathy: a report of two cases","volume":"5","author":"Gladue","year":"2014","journal-title":"J Clin Cell Immunol"},{"key":"R84-20250603","first-page":"38","article-title":"Incomplete Schnitzler syndrome","volume":"28","author":"Henning","year":"2020","journal-title":"Acta Dermatovenerol Croat"},{"key":"R85-20250603","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/03009742.2015.1071421","article-title":"Delayed development of the IgM paraprotein in Schnitzler's syndrome","volume":"44","author":"Mulla","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"R86-20250603","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3899\/jrheum.181204","article-title":"Monoclonal gammopathy, arthralgias, and recurrent fever syndrome: a new autoinflammatory syndrome?","volume":"46","author":"Terr\u00e9","year":"2019","journal-title":"J Rheumatol"},{"key":"R87-20250603","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2340\/00015555-0233","article-title":"Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG","volume":"87","author":"Treudler","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"R88-20250603","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3899\/jrheum.091200","article-title":"Chronic urticaria and arthritis with polyclonal IgA: rapid response and clinical remission with interleukin 1 blockade","volume":"37","author":"Chu","year":"2010","journal-title":"J Rheumatol"},{"key":"R89-20250603","first-page":"272","article-title":"Schnitzler's syndrome without monoclonal gammop-athy","volume":"85","author":"Varella","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R90-20250603","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1007\/s10067-020-05501-w","article-title":"Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review","volume":"40","author":"Bixio","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R91-20250603","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2133.2000.03394.x","article-title":"Severe course of chronic urticaria, arthralgia, fever and elevation of erythrocyte sedimentation rate: Schnitzler's syndrome without monoclonal gammopathy?","volume":"142","author":"Husak","year":"2000","journal-title":"Br J Dermatol"},{"key":"R92-20250603","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1203475416657999","article-title":"Schnitzler syndrome without a monoclonal gammopathy: a case report","volume":"20","author":"Urbanski","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"R93-20250603","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3349\/ymj.2018.59.1.154","article-title":"A case of Schnitzler's syndrome without monoclonal gammopathy-associated chronic urticaria treated with anakinra","volume":"59","author":"Ahn","year":"2018","journal-title":"Yonsei Med J"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:05:22Z","timestamp":1748977522000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002015","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}